loadpatents
name:-0.07707405090332
name:-0.058678865432739
name:-0.0080749988555908
Nagarathnam; Dhanapalan Patent Filings

Nagarathnam; Dhanapalan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nagarathnam; Dhanapalan.The latest application filed is for "novel selective pi3k delta inhibitors".

Company Profile
8.62.70
  • Nagarathnam; Dhanapalan - Bethany CT
  • Nagarathnam; Dhanapalan - La Chaux-de-Fonds CH
  • Nagarathnam; Dhanapalan - Princeton NJ
  • Nagarathnam; Dhanapalan - Ramsey NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Novel Compounds As Modulators Of Protein Kinases
App 20210401840 - Nagarathnam; Dhanapalan ;   et al.
2021-12-30
Novel Selective Pi3k Delta Inhibitors
App 20210403475 - Vakkalanka; Swaroop K. ;   et al.
2021-12-30
Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine And 3,5- Disubstituted -3h-[1,2,3]triazolo[4,5-b] Pyridine Compounds As Modulators Of C-met Protein Kinases
App 20210371416 - Vakkalanka; Swaroop K. V. S. ;   et al.
2021-12-02
3,5-disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases
Grant 11,066,402 - Vakkalanka , et al. July 20, 2
2021-07-20
Nucleoside Phosphoramidate Prodrugs
App 20210196741 - Du; Jinfa ;   et al.
2021-07-01
Intermediates useful in the synthesis of compounds as modulators of protein kinases
Grant 11,020,399 - Nagarathnam , et al. June 1, 2
2021-06-01
Selective PI3K delta inhibitors
Grant 10,981,919 - Vakkalanka , et al. April 20, 2
2021-04-20
Novel Selective Pi3k Delta Inhibitors
App 20200270258 - Vakkalanka; Swaroop K ;   et al.
2020-08-27
Selective PI3K delta inhibitors
Grant 10,570,142 - Vakkalanka , et al. Feb
2020-02-25
Novel Compounds As Modulators Of Protein Kinases
App 20190282581 - Nagarathnam; Dhanapalan ;   et al.
2019-09-19
Novel Selective Pi3k Delta Inhibitors
App 20190194206 - Vakkalanka; Swaroop K. ;   et al.
2019-06-27
Substituted chromenones as modulators of protein kinases
Grant 10,322,130 - Nagarathnam , et al.
2019-06-18
Substituted Chromenones As Modulators Of Protein Kinases
App 20190105324 - Nagarathnam; Dhanapalan ;   et al.
2019-04-11
Compounds as modulators of protein kinases
Grant 10,220,035 - Nagarathnam , et al.
2019-03-05
Nucleoside phosphoramidate prodrugs
Grant 10,183,037 - Du , et al. Ja
2019-01-22
Selective PI3K delta inhibitors
Grant 10,072,013 - Vakkalanka , et al. September 11, 2
2018-09-11
Novel Compounds As Modulators Of Protein Kinases
App 20180110783 - Nagarathnam; Dhanapalan ;   et al.
2018-04-26
Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine And 3,5-disubstituted-3h-[1,2,3]triazolo[4,5-b] Pyridine Compounds As Modulators Of C-met Protein Kinases
App 20180072721 - Vakkalanka; Swaroop K. V. S. ;   et al.
2018-03-15
Nucleoside Phosphoramidate Prodrugs
App 20180000855 - Du; Jinfa ;   et al.
2018-01-04
Novel Compounds As Modulators Of Gpr-119
App 20170342089 - Nagarathnam; Dhanapalan ;   et al.
2017-11-30
3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases
Grant 9,815,831 - Vakkalanka , et al. November 14, 2
2017-11-14
Compounds as modulators of protein kinases
Grant 9,775,841 - Nagarathnam , et al. October 3, 2
2017-10-03
Compounds as modulators of GPR-119
Grant 9,777,018 - Nagarathnam , et al. October 3, 2
2017-10-03
Novel Selective Pi3k Delta Inhibitors
App 20170204105 - Vakkalanka; Swaroop Kumar V.S. ;   et al.
2017-07-20
Selective PI3K delta inhibitors
Grant 9,669,033 - Vakkalanka , et al. June 6, 2
2017-06-06
Nucleoside phosphoramidate prodrugs
Grant 9,585,906 - Du , et al. March 7, 2
2017-03-07
Novel Selective Pi3k Delta Inhibitors
App 20170020881 - VAKKALANKA; Swaroop Kumar V.S. ;   et al.
2017-01-26
Selective PI3K delta inhibitors
Grant 9,475,818 - Vakkalanka , et al. October 25, 2
2016-10-25
Novel Compounds As Modulators Of Gpr-119
App 20150361092 - Nagarathnam; Dhanapalan ;   et al.
2015-12-17
Novel Selective Pi3k Delta Inhibitors
App 20150361083 - VAKKALANKA; Swaroop Kumar V.S. ;   et al.
2015-12-17
Novel Compounds As Modulators Of Protein Kinases
App 20150320752 - NAGARATHNAM; Dhanapalan ;   et al.
2015-11-12
Bicyclic compounds as modulators of GPR-119
Grant 9,181,214 - Nagarathnam , et al. November 10, 2
2015-11-10
Selective PI3K delta inhibitors
Grant 9,150,579 - Vakkalanka , et al. October 6, 2
2015-10-06
Nucleoside Phosphoramidate Prodrugs
App 20150231166 - Du; Jinfa ;   et al.
2015-08-20
Nucleoside phosphoramidate prodrugs
Grant 9,085,573 - Du , et al. July 21, 2
2015-07-21
Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine And 3,5- Disubstituted -3h-[1,2,3]triazolo[4,5-b] Pyridine Compounds As Modulators Of C-met Protein, Etc
App 20150057309 - Vakkalanka; Swaroop K. V. S. ;   et al.
2015-02-26
Nucleoside phosphoramidates
Grant 8,957,045 - Sofia , et al. February 17, 2
2015-02-17
Nucleoside phosphoramidate prodrugs
Grant 8,957,046 - Du , et al. February 17, 2
2015-02-17
Nucleoside phosphoramidate prodrugs
Grant 8,906,880 - Du , et al. December 9, 2
2014-12-09
Nucleoside Phosphoramidate Prodrugs
App 20140315852 - Du; Jinfa ;   et al.
2014-10-23
Nucleoside Phosphoramidate Prodrugs
App 20140288020 - Du; Jinfa ;   et al.
2014-09-25
Nucleoside Phosphoramidate Prodrugs
App 20140187511 - Du; Jinfa ;   et al.
2014-07-03
Nucleoside cyclicphosphates
Grant 8,759,510 - Du , et al. June 24, 2
2014-06-24
Nucleoside phosphoramidate prodrugs
Grant 8,735,372 - Du , et al. May 27, 2
2014-05-27
Nucleoside phosphoramidates
Grant 8,716,262 - Sofia , et al. May 6, 2
2014-05-06
Synthesis of purine nucleosides
Grant 8,716,263 - Chun , et al. May 6, 2
2014-05-06
Nucleoside Phosphoramidate Prodrugs
App 20140045783 - Du; Jinfa ;   et al.
2014-02-13
Novel Selective Pi3k Delta Inhibitors
App 20140011819 - VAKKALANKA; Swaroop Kumar V.S. ;   et al.
2014-01-09
Nucleoside phosphoramidate prodrugs
Grant 8,580,765 - Sofia , et al. November 12, 2
2013-11-12
Purine nucleoside phosphoramidate
Grant 8,563,530 - Chang , et al. October 22, 2
2013-10-22
Nucleoside analogs
Grant 8,551,973 - Bao , et al. October 8, 2
2013-10-08
Nucleoside Phosphoramidates
App 20130225519 - SOFIA; Michael Joseph ;   et al.
2013-08-29
Novel Compounds As Modulators Of Gpr-119
App 20130045986 - NAGARATHNAM; Dhanapalan ;   et al.
2013-02-21
Nucleoside Phosphoramidate Prodrugs
App 20130029929 - Sofia; Michael Joseph ;   et al.
2013-01-31
Nucleoside phosphoramidate prodrugs
Grant 8,334,270 - Sofia , et al. December 18, 2
2012-12-18
Synthesis Of Purine Nucleosides
App 20120316327 - Chun; Byoung-Kwon ;   et al.
2012-12-13
Novel Compounds As Modulators Of Protein Kinases
App 20120289496 - NAGARATHNAM; Dhanapalan ;   et al.
2012-11-15
Nucleoside Cyclicphosphates
App 20120258928 - DU; JINFA ;   et al.
2012-10-11
Nucleoside cyclicphosphates
Grant 8,173,621 - Du , et al. May 8, 2
2012-05-08
Rho-Kinase Inhibitors
App 20120053179 - Nagarathnam; Dhanapalan ;   et al.
2012-03-01
Hydroxy methyl phenyl pyrazolyl urea compounds useful in the treatment of cancer
Grant 8,101,773 - Smith , et al. January 24, 2
2012-01-24
Substituted Pyridines And Pyridazines With Angiogenesis Inhibiting Activity
App 20110263597 - Dumas; Jacques P. ;   et al.
2011-10-27
Purine Nucleoside Phosphoramidate
App 20110257121 - CHANG; WONSUK ;   et al.
2011-10-20
Urea Compounds Useful In The Treatment Of Cancer
App 20110195110 - Smith; Roger ;   et al.
2011-08-11
Substituted pyridines and pyridazines with angiogenesis inhibiting activity
Grant 7,977,333 - Dumas , et al. July 12, 2
2011-07-12
Pyrimidine Derivatives for Treatment of Hyperproliferative Disorders
App 20110098301 - Dixon; Julie A. ;   et al.
2011-04-28
Nucleoside Phosphoramidates
App 20110015146 - SOFIA; MICHAEL JOSEPH ;   et al.
2011-01-20
Nucleoside Analogs
App 20100286083 - BAO; DONGHUI ;   et al.
2010-11-11
Synthesis Of Purine Nucleosides
App 20100279973 - CHUN; BYOUNG-KWON ;   et al.
2010-11-04
Rho-kinase Inhibitors
App 20100249159 - Nagarathnam; Dhanapalan ;   et al.
2010-09-30
Rho-kinase Inhibitors
App 20100216789 - NAGARATHNAM; Dhanapalan ;   et al.
2010-08-26
Hydroxy Methyl Phenyl Pyrazolyl Urea Compound Useful In Treatment Of Cancer
App 20100150863 - Smith; Roger ;   et al.
2010-06-17
Nucleoside Cyclicphosphates
App 20100081628 - DU; Jinfa ;   et al.
2010-04-01
Pyrimidine Derivatives For Treatment Of Hyperproliferative Disorders
App 20100075967 - Dixon; Julie A. ;   et al.
2010-03-25
Pyrimidine derivatives for treatment of hyperproliferative disorders
Grant 7,678,804 - Dixon , et al. March 16, 2
2010-03-16
Hydroxy Methyl Phenyl Pyrazolyl Urea Compounds Usefull In The Treatment Of Cancer
App 20100063107 - Smith; Roger ;   et al.
2010-03-11
Nucleoside Phosphoramidate Prodrugs
App 20100016251 - SOFIA; MICHAEL JOSEPH ;   et al.
2010-01-21
Substituted thieno[3,2-D]pyrimidines as Rho kinase inhibitors
Grant 7,648,986 - Nagarathnam , et al. January 19, 2
2010-01-19
Pyrimidine Derivatives
App 20090286785 - Nagarathnam; Dhanapalan ;   et al.
2009-11-19
Pyrimidine Derivatives
App 20090258888 - Nagarathnam; Dhanapalan ;   et al.
2009-10-15
Pyrimidine derivatives for treatment of hyperproliferative disorders
Grant 7,582,645 - Dixon , et al. September 1, 2
2009-09-01
Rho-kinase Inhibitors
App 20070238741 - Nagarathnam; Dhanapalan ;   et al.
2007-10-11
Quinolone Carboxylic Acid Derivatives for Treatment of Hyperproliferative Conditions
App 20070213339 - Khire; Uday ;   et al.
2007-09-13
Pyrimidine derivatives for treatment of hyperproliferative disorders
App 20070117817 - Dixon; Julie A. ;   et al.
2007-05-24
Method of treating cancer with quinolone carboxylic acid derivatives
App 20060142295 - Dumas; Jacques ;   et al.
2006-06-29
Rho-kinase inhibitors
App 20060142314 - Nagarathnam; Dhanapalan ;   et al.
2006-06-29
Pyrimidine derivatives for treatment of hyperproliferative disorders
App 20050277640 - Dixon, Julie A. ;   et al.
2005-12-15
Rho-kinase inhibitors
App 20050209261 - Nagarathnam, Dhanapalan ;   et al.
2005-09-22
Rho-kinase inhibitors
Grant 6,943,172 - Nagarathnam , et al. September 13, 2
2005-09-13
Rho-kinase inhibitors
App 20050192304 - Nagarathnam, Dhanapalan ;   et al.
2005-09-01
Rho-kinase inhibitors
Grant 6,924,290 - Nagarathnam , et al. August 2, 2
2005-08-02
Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity
Grant 6,903,101 - Dumas , et al. June 7, 2
2005-06-07
Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
App 20040242609 - Marzabadi, Mohammad R. ;   et al.
2004-12-02
Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-.gamma. binding agents
Grant 6,787,651 - Stolle , et al. September 7, 2
2004-09-07
Dihydropyrimidines and uses thereof
App 20040138242 - Cui, Donghui ;   et al.
2004-07-15
Substituted pyridines and pyridazines with angiogenesis inhibiting activity
App 20040092740 - Dumas, Jacques P. ;   et al.
2004-05-13
5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
Grant 6,727,257 - Nagarathnam , et al. April 27, 2
2004-04-27
Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
Grant 6,720,324 - Marzabadi , et al. April 13, 2
2004-04-13
Substituted pyridines and pyridazines with angiogenesis inhibiting activity
Grant 6,689,883 - Dumas , et al. February 10, 2
2004-02-10
Rho-kinase inhibitors
App 20040014755 - Nagarathnam, Dhanapalan ;   et al.
2004-01-22
Dihydropyrimidines and uses thereof
Grant 6,680,323 - Cui , et al. January 20, 2
2004-01-20
Rho-kinase inhibitors
App 20040002507 - Nagarathnam, Dhanapalan ;   et al.
2004-01-01
Rho-kinase inhibitors
App 20040002508 - Nagarathnam, Dhanapalan ;   et al.
2004-01-01
Morpholinone and morpholine derivatives and uses thereof
App 20030212062 - Lagu, Bharat ;   et al.
2003-11-13
Oxazolidinones and uses thereof
Grant 6,620,815 - Lagu , et al. September 16, 2
2003-09-16
Dihydropyridines and new uses thereof
Grant 6,608,086 - Gluchowski , et al. August 19, 2
2003-08-19
Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents
App 20030087902 - Stolle, Andreas ;   et al.
2003-05-08
Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
App 20030069261 - Marzabadi, Mohammad R. ;   et al.
2003-04-10
Dihydropyridines and new uses thereof
App 20020193599 - Gluchowski, Charles ;   et al.
2002-12-19
Morpholinone and morpholine derivatives and uses thereof
App 20020068737 - Lagu, Bharat ;   et al.
2002-06-06
Dihydropyrimidines and uses thereof
App 20020010186 - Wong, Wai C. ;   et al.
2002-01-24
Dihydropyrimidines and uses thereof
App 20010041707 - Cui, Donghui ;   et al.
2001-11-15
Dihydropyrimidines and uses thereof
Grant 6,274,585 - Cui , et al. August 14, 2
2001-08-14
5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
Grant 6,268,369 - Nagarathnam , et al. July 31, 2
2001-07-31
5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
Grant 6,248,747 - Nagarathnam , et al. June 19, 2
2001-06-19
5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
Grant 6,245,773 - Wong , et al. June 12, 2
2001-06-12
Dihydropyrimidines and uses thereof
Grant 6,228,861 - Nagarathnam , et al. May 8, 2
2001-05-08
Morpholinone and morpholine derivatives and uses thereof
Grant 6,218,390 - Lagu , et al. April 17, 2
2001-04-17
Dihydropyrimidines and uses thereof
Grant 6,172,066 - Nagarathnam , et al. January 9, 2
2001-01-09
Oxazolidinones as .alpha..sub.1A receptor antagonists
Grant 6,159,990 - Lagu , et al. December 12, 2
2000-12-12
5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
Grant 5,942,517 - Nagarathnam , et al. August 24, 1
1999-08-24
Dihydropyridines and new uses thereof
Grant 5,767,131 - Gluchowski , et al. June 16, 1
1998-06-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed